Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model

British Journal of Cancer

Volumn 97, Issue 10, 2007, Pages 1432-1440

  Niedergethmann, M ^a   Alves, F ^b   Neff, J K ^a   Heidrich, B ^a   Aramin, N ^a   Li, L ^c   Pilarsky, C ^d   Grutzmann R ^d   Allgayer, H ^c   Post, S ^a   Gretz, N ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Angiogenesis; Apoptosis; Cell migration; Gene expression profiling; Overrepresentation analysis; Pancreatic cancer

Indexed keywords

ENOLASE 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HEAT SHOCK PROTEIN 27; PROTEIN; PROTEIN BNIP3; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR TYPE 14; RGS4 PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER MODEL; CANCER TISSUE; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELL METABOLISM; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA BASE; DOWN REGULATION; FEMALE; FROZEN SECTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; SCID MOUSE; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 36148988790     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604031     Document Type: Article

References (49)

1. Albig AR, Schiemann WP (2005) Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Mol Biol Cell 16: 609-625
2. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554
3. Alves F, Contag S, Missbach M, Kaspareit J, Nebendahl K, Borchers U, Heidrich B, Streich R, Hiddemann W (2001) An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade. Pancreas 23: 227-235
4. Beyer BC, Heiss MM, Simon EH, Gruetzner KU, Babic R, Jauch KW, Schildberg FW, Allgayer H (2006) Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens. Cancer 106: 1026-1035
5. Chott A, Kloppel G, Buxbaum P, Heitz PU (1987) Neuron specific enolase demonstration in the diagnosis of a solid-cystic (papillary cystic) tumour of the pancreas. Virchows Arch A Pathol Anat Histopathol 410: 397-402
6. D'Alessandro M, Mariani P, Lomanto D, Carlei F, Lezoche E, Speranza V (1992) Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors. Tumour Biol 13: 352-357
7. Dong M, Zhou JP, Kong FM, Guo KJ, Tian YL, Dong YT (2005) [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27: 628-632
8. Eskelinen MJ, Haglund UH (1999) Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods. Eur J Surg 165: 292-306
9. Freiss G, Vignon F (2004) Protein tyrosine phosphatases and breast cancer. Crit Rev Oncol Hematol 52: 9-17
10. Fukuhara M, Uchida E, Tajiri T, Aimoto T, Naito Z, Ishiwata T (2005) Reexpression of reduced VEGF activity in liver metastases of experimental pancreatic cancer. J Nippon Med Sch 72: 155-164
11. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183
12. Grützmann R, Saeger HD, Lüttges J, Schackert HK, Kalthoff H, Klöppel G, Pilarsky C (2004) Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspective. Int J Colorectal Dis 19: 401-413
13. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353
14. Han H, Bearss DJ, Brown LW, Calaluce R, Nagle RB, Von Hoff DD (2002) Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62: 2890-2896
15. Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M, Post S (2002) Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 168: 707-712
16. Higashi H, Vallbohmer D, Warnecke-Eberz U, Hokita S, Xi H, Brabender J, Metzger R, Baldus SE, Natsugoe S, Aikou T, Holscher AH, Schneider PM (2006) Downregulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer. Anticancer Res 26: 2143-2147
17. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace Jr AJ (1999) Genomic instability in Gadd45a-deficient mice. Nat Genet 23: 176-184
18. Hruban RH, Offerhaus GJ, Kern SE, Goggins M, Wilentz RE, Yeo CJ (1998) Tumor-suppressor genes in pancreatic cancer. J Hepatobiliary Pancreat Surg 5: 383-391
19. Hsieh WP, Chu TM, Wolfinger RD, Gibson G (2003) Mixed-model reanalysis of primate data suggests tissue and species biases in oligonucleotide-based gene expression profiles. Genetics 165: 747-757
20. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH (2003a) Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63: 8614-8622
21. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins M (2003b) Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162: 1151-1162
22. Inoue M, Sawada T, Uchima Y, Kimura K, Nishihara T, Tanaka H, Yashiro M, Yamada N, Ohira M, Hirakawa K (2005) Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis. Oncol Rep 14: 1445-1451
23. Jemal A, Murray T, Samuels A, Ward Ean d Thun MJ (2003) Cancer statistics. CA Cancer J Clin 9: 43-44
24. Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele HG, Honold G, Pantel K, Riethmuller G (1993) p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 8: 289-298
25. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, Ishikawa O, Katagiri T, Tsunoda T, Nakamura Y, Furukawa Y (2004) Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24: 305-312
26. Lindberg P, Larsson A, Nielsen BS (2006) Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma. Int J Cancer 118: 2948-2956
27. Lo Muzio L, Campisi G, Farina A, Rubini C, Ferrari F, Falaschini S, Leonardi R, Carinci F, Stalbano S, De Rosa G (2006) Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours. Anticancer Res 26: 1343-1349
28. Manoli T, Gretz N, Grone HJ, Kenzelmann M, Eils R, Brors B (2006) Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics 22: 2500-2506
29. Massaron S, Seregni E, Luksch R, Casanova M, Botti C, Ferrari L, Martinetti A, Molteni SN, Bellani FF, Bombardieri E (1998) Neuron-specific enolase evaluation in patients with neuroblastoma. Tumour Biol 19: 261-268
30. Melle C, Ernst G, Escher N, Hartmann D, Schimmel B, Bleul A, Thieme H, Kaufmann R, Felix K, Friess HM, Settmacher U, Hommann M, Richter KK, Daffner W, Taubig H, Manger T, Claussen U, von Eggeling F (2007) Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem 15: 15
31. Nakamura T, Fidler IJ, Coombes KR (2007) Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res 67: 139-148
32. Niedergethmann M, Hildenbrand R, Wostbrock B, Hartel M, Sturm JW, Richter A, Post S (2002) High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 25: 122-129
33. Niedergethmann M, Wostbrock B, Sturm JW, Willeke F, Post S, Hildenbrand R (2004) Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma. Pancreas 29: 204-211
34. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R (2004) Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-750
35. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27: 324-329
36. Roy J (2007) SAS for mixed models. In J Biopharm Stat, Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O (eds), 2nd edn, Vol. 17, pp 363-365
37. Sawai H, Okada Y, Funahashi H, Matsuo Y, Takeyama H, Manabe T (2005) Anaplastic carcinoma of the pancreas with squamous features: report of a case and immunohistochemical study. Med Sci Monit 11: CS65-CS68
38. Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM, Liptay S (2006) GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability. Int J Cancer 118: 2405-2411
39. Slebos RJ, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, Bracci PM, Foley J, Stockton P, McGregor LM, Flake GP, Taylor JA (2000) K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev 9: 1223-1232
40. Smith R, Xue A, Gill A, Scarlett C, Saxby A, Clarkson A, Hugh T (2007) High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. World J Surg 31: 493-502
41. Song LH, Song XR, Zhang XQ, Qi JL, Li XJ, Tian H, Bu B (2004) [Prognostic factors in patients with small cell lung cancer]. Zhonghua Zhong Liu Za Zhi 26: 413-416
42. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550
43. Sun JL, He XS, Yu YH, Chen ZC (2004) [Expression and structure of BNIP3L in lung cancer]. Ai Zheng 23: 8-14
44. Takeuchi Y, Nakao A, Harada A, Nonami T, Fukatsu T, Takagi H (1993) Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study. Am J Gastroenterol 88: 1928-1933
45. Trede M, Richter A, Wendl K (2001) Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 81: 595-610
46. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, Ptak J, Silliman N, Peters BA, van der Heijden MS, Parmigiani G, Yan H, Wang TL, Riggins G, Powell SM, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304: 1164-1166
47. Westphal S, Kalthoff H (2003) Apoptosis: targets in pancreatic cancer. Mol Cancer 2: 6
48. Yunis AA, Arimura GK, Russin DJ (1977) Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer 19: 128-135
49. Zucchi I, Mento E, Kuznetsov VA, Scotti M, Valsecchi V, Simionati B, Vicinanza E, Valle G, Pilotti S, Reinbold R, Vezzoni P, Albertini A, Dulbecco R (2004) Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci USA 101: 18147-18152